Dr Jackfruit India Profile
Key Indicators
- Authorised Capital ₹ 3.55 M
as on 17-11-2024
- Paid Up Capital ₹ 2.95 M
as on 17-11-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 Cr
as on 17-11-2024
- Satisfied Charges ₹ 1.00 Cr
as on 17-11-2024
- Revenue 401.99%
(FY 2023)
- Profit -12517.58%
(FY 2023)
- Ebitda -10477.15%
(FY 2023)
- Net Worth -90.85%
(FY 2023)
- Total Assets 61.24%
(FY 2023)
About Dr Jackfruit India
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.55 M and a paid-up capital of Rs 2.95 M.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manas Vadasseril, Madhu Gopalan, and Jyoti Rajguru serve as directors at the Company.
- CIN/LLPIN
U15490KL2018PTC053058
- Company No.
053058
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Alappuzha, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dr Jackfruit India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manas Vadasseril  | Director | 25-Apr-2018 | Current |
| Madhu Gopalan | Director | 25-Apr-2018 | Current |
| Jyoti Rajguru | Director | 28-Jul-2022 | Current |
Financial Performance of Dr Jackfruit India.
Dr Jackfruit India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 401.99% increase. The company also saw a substantial fall in profitability, with a 12517.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 90.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Jackfruit India?
In 2023, Dr Jackfruit India had a public holding of 2.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 22 May 2024 | ₹5.00 Cr | Open |
Others Creation Date: 09 Nov 2022 | ₹3.00 Cr | Open |
Others Creation Date: 05 Dec 2022 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Dr Jackfruit India?
Dr Jackfruit India has a workforce of 29 employees as of Oct 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Jackfruit India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Jackfruit India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
